lidocaine has been researched along with sotalol in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (34.43) | 18.7374 |
1990's | 14 (22.95) | 18.2507 |
2000's | 13 (21.31) | 29.6817 |
2010's | 13 (21.31) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Bianucci, AM; Calderone, V; Coi, A; Massarelli, I; Testai, L | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Calogeropoulou, T; Horváth, Z; Koini, EN; Koncz, I; Koufaki, M; Papazafiri, P; Papp, GJ; Varró, A; Vassilopoulos, A; Virág, L | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kelliher, GJ; Roberts, J; Widmer, C | 1 |
Frierson, JL; Honig, CR | 1 |
Courtney, KR; Hill, BC; Hunt, AJ | 1 |
Cheymol, G; Chézalviel, F; Davy, JM; Engel, F; Ertzbischoff, O; Lainée, P; Motté, G; Penin, E; Poirier, JM; Weissenburger, J | 1 |
Camm, AJ; Garratt, CJ; Griffith, MJ; Linker, NJ; Ward, DE | 1 |
Lathrop, DA; Varró, A | 2 |
Gomi, Y; Inagaki, O; Kasuya, Y; Ono, K; Suzuki, N | 1 |
Lüderitz, B; Manz, M; Wagner, WL | 1 |
Hoffman, BF; Spinelli, W | 1 |
Lüderitz, B; Nitsch, J; Schmid, C | 1 |
Engel, T; Kelliher, GJ; Kowey, P; Wetstein, L | 1 |
Beyer, T; Brachmann, J; Kübler, W; Schmitt, C; Schöls, W | 1 |
Huang, SK; Marcus, FI | 1 |
Almgren, O; Axenborg, J; Duker, G | 1 |
Allessie, MA; Bonke, FI; Lammers, WJ; Rensma, PL; Schalij, MJ | 1 |
Gülker, H; Haverkamp, W; Hindricks, G; Thale, J | 1 |
Feld, GK; Singh, BN; Venkatesh, N | 1 |
Lavender, MK; Parkes, MW | 1 |
Day, MD; Roach, AG | 1 |
Davis, LD; Koerpel, BJ | 1 |
Ohkawa, H; Prosser, CL | 1 |
Amess, J; Cole, P; Roberts, M; Taylor, EA; Trembath, PW; Turner, P | 1 |
Atallah, G; Kirkorian, G; Moleur, P; Touboul, P | 1 |
Pellinen, T; Tötterman, KJ; Turto, H | 1 |
Carlsson, B; Drvota, V; Häggblad, J; Sylvén, C | 1 |
Janssen, JH | 1 |
Ho, DS; Richards, DA; Ross, DL; Uther, JB; Zecchin, RP | 1 |
Gutiérrez-Larraya, F; Jabón, A | 1 |
Armstrong, JM; Bellemin-Baurreau, J; Hicks, PE; Poizot, A | 1 |
Chatelain, P; Finance, O; Manning, A | 1 |
Bruyninckx, C; Chatelain, P; Manning, AS; Ramboux, J | 1 |
Assimes, TL; Malcolm, I | 1 |
Singh, BN | 1 |
Miller, AW; Sims, JJ; Ujhelyi, MR | 1 |
Brandts, B; Trappe, HJ; Weismueller, P | 1 |
Adelstein, BA; Hall, J; Ho, D; Kovoor, P; Kruit, R; Love, A; Ross, DL; Sadick, N | 1 |
Braam, SR; Meyer, T; Mummery, CL; Passier, R; Tertoolen, L; van de Stolpe, A | 1 |
Bhandari, A; Dow, JS; Kloner, RA | 1 |
Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP | 1 |
DeLillo, DM; Jesty, SA; Souza, MJ | 1 |
Koyfman, A; Long, B | 1 |
Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B | 1 |
8 review(s) available for lidocaine and sotalol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacology of antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Calcium Channel Blockers; Electrophysiology; Encainide; Flecainide; Heart Conduction System; Humans; Lidocaine; Moricizine; Phenothiazines; Piperidines; Quaternary Ammonium Compounds; Sotalol; Tocainide | 1985 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
[New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Sotalol; Tocainide | 1982 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiography; Ergometry; Flecainide; Heart; Heart Ventricles; Humans; Infant; Infant, Newborn; Lidocaine; Middle Aged; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Tachycardia, Ventricular | 1993 |
Torsade de pointes with sotalol overdose treated successfully with lidocaine.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Drug Overdose; Electrocardiography; Follow-Up Studies; Humans; Infusions, Intravenous; Lidocaine; Male; Sotalol; Torsades de Pointes | 1998 |
Arrhythmias in the intensive care patient.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Critical Care; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Hemodynamics; Humans; Lidocaine; Sotalol; Tachycardia; Tachycardia, Ventricular | 2003 |
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, Hospital; Evidence-Based Medicine; Humans; Lidocaine; Procainamide; Pyrimidinones; Review Literature as Topic; Sotalol; Tachycardia, Ventricular | 2017 |
5 trial(s) available for lidocaine and sotalol
Article | Year |
---|---|
Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Disopyramide; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Flecainide; Humans; Hypotension; Injections, Intravenous; Lidocaine; Middle Aged; Recurrence; Sotalol; Tachycardia | 1990 |
[Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; Female; Heart Ventricles; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Sotalol; Tocainide | 1987 |
The haemoglobin-oxygen dissociation curve: in vivo and in vitro effects of five beta-adrenoceptor antagonists and lignocaine.
Topics: Adrenergic beta-Antagonists; Adult; Erythrocytes; Hemoglobins; Humans; Lidocaine; Oxygen; Propranolol; Sotalol; Time Factors | 1981 |
Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; Sotalol; Tachycardia, Ventricular | 1994 |
Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia.
Topics: Aged; Anti-Arrhythmia Agents; Female; Follow-Up Studies; Heart Arrest; Humans; Lidocaine; Male; Outpatients; Retrospective Studies; Sotalol; Treatment Outcome; Ventricular Fibrillation | 2005 |
48 other study(ies) available for lidocaine and sotalol
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation.
Topics: Amino Acid Sequence; Heart; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Protein Subunits; Sequence Alignment; Structure-Activity Relationship; Trans-Activators; Transcriptional Regulator ERG | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
5,7,8-Trimethyl-benzopyran and 5,7,8-trimethyl-1,4-benzoxazine aminoamide derivatives as novel antiarrhythmics against ischemia-reperfusion injury.
Topics: Action Potentials; Amides; Animals; Anti-Arrhythmia Agents; Antioxidants; Benzopyrans; Benzoxazines; Female; Heart; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; Papillary Muscles; Rabbits; Rats; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Influence of the adrenal medulla on cardiac rhythm disturbances following acute coronary artery occlusions.
Topics: Adrenal Medulla; Animals; Arrhythmias, Cardiac; Cats; Coronary Disease; Epinephrine; Female; Lidocaine; Ligation; Male; Practolol; Sotalol; Time Factors; Veins; Ventricular Fibrillation | 1975 |
Neurons intrinsic to arterioles initiate postcontraction vasodilation.
Topics: Animals; Arteries; Atropine; Blood Pressure; Denervation; Dipyridamole; Dogs; Gallamine Triethiodide; Hexamethonium Compounds; Lidocaine; Muscle Contraction; Neurons; Oxygen; Oxygen Consumption; Procaine; Propantheline; Propranolol; Regional Blood Flow; Sotalol; Vascular Resistance | 1976 |
Reentrant tachycardia in a thin layer of ventricular subepicardium: effects of d-sotalol and lidocaine.
Topics: Action Potentials; Animals; Electric Stimulation; Electrophysiology; Freezing; Heart Ventricles; In Vitro Techniques; Lidocaine; Rabbits; Refractory Period, Electrophysiological; Sotalol; Tachycardia | 1990 |
Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Bradycardia; Consciousness; Diuretics; Dogs; Electrocardiography, Ambulatory; Electrolytes; Electrophysiology; Female; Flecainide; Heart Block; Hypocalcemia; Lidocaine; Male; Propranolol; Quinidine; Sotalol | 1991 |
The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate-dependent.
Topics: Animals; Cardiac Pacing, Artificial; Dogs; Electrophysiology; Female; Heart; Heart Conduction System; Heart Rate; In Vitro Techniques; Lidocaine; Male; Purkinje Fibers; Sotalol | 1990 |
Propranolol blocks cocaine-induced potentiation of the contraction in the smooth muscle of the rat vas deferens.
Topics: Animals; Cocaine; In Vitro Techniques; Lidocaine; Male; Membrane Potentials; Muscle Contraction; Muscle, Smooth; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Vas Deferens | 1990 |
Modulation of the effects of sotalol on Purkinje strand electromechanical characteristics.
Topics: Animals; Dogs; Electrophysiology; Heart; Heart Conduction System; In Vitro Techniques; Ion Channels; Lidocaine; Membrane Potentials; Myocardium; Niacinamide; Nicorandil; Purkinje Fibers; Sotalol; Tetraethylammonium Compounds; Veratrine | 1989 |
Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Disopyramide; Dogs; Electrocardiography; Flecainide; Heart Conduction System; Heart Rate; Lidocaine; Piperidines; Propafenone; Sotalol | 1989 |
Acute induction of sustained ventricular tachycardia: a new porcine model.
Topics: Animals; Disease Models, Animal; Electric Stimulation; Electrocardiography; Heart; Heart Ventricles; Lidocaine; Myocardial Infarction; Sotalol; Swine; Tachycardia; Time Factors; Ventricular Fibrillation | 1989 |
[Proarrhythmic effect of ajmaline in idiopathic ventricular tachycardia].
Topics: Adult; Ajmaline; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Infusions, Intravenous; Lidocaine; Sotalol; Tachycardia | 1989 |
Computerized evaluation of drug-induced changes in guinea-pig epicardial monophasic action potentials.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Electrodes; Guinea Pigs; Lidocaine; Pericardium; Sotalol; Tocainide | 1988 |
Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs.
Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Dogs; Female; Heart Conduction System; Lidocaine; Male; Neural Conduction; Ouabain; Physical Exertion; Propafenone; Quinidine; Refractory Period, Electrophysiological; Sotalol | 1988 |
Comparative investigations on the antiarrhythmic and electrophysiologic effects of class I-IV antiarrhythmic agents following acute coronary artery occlusion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Dogs; Female; Heart Conduction System; Lidocaine; Male; Metoprolol; Myocardial Infarction; Sotalol; Ventricular Fibrillation; Verapamil | 1987 |
Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
Topics: Animals; Atrial Flutter; Cardiac Pacing, Artificial; Dogs; Drug Evaluation; Electrocardiography; Electrophysiology; Heart Conduction System; Lidocaine; Neural Conduction; Quinidine; Refractory Period, Electrophysiological; Sotalol; Time Factors | 1986 |
The activity of beta-adrenoceptor blocking agents in protecting mice from the cardiotoxic effects of ouabain.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Animals; Anti-Arrhythmia Agents; Diazepam; Dose-Response Relationship, Drug; Electrocardiography; Ethanolamines; Lidocaine; Male; Mice; Mice, Inbred Strains; Nitrobenzenes; Ouabain; Phenethylamines; Propranolol; Propylamines; Quinidine; Sotalol | 1973 |
Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats.
Topics: Albuterol; Alprenolol; Animals; Atropine; Bethanidine; Blood Pressure; Cats; Cerebral Ventricles; Clonidine; Dopamine; Epinephrine; Female; Heart Rate; Hexamethonium Compounds; Injections; Isoproterenol; Lidocaine; Male; Norepinephrine; Pempidine; Phentolamine; Practolol; Propranolol; Rabbits; Rats; Receptors, Adrenergic; Sotalol; Species Specificity; Time Factors | 1974 |
Effects of lidocaine, propranolol, and sotalol on ouabain-induced changes in transmembrane potential of canine Purkinje fibers.
Topics: Action Potentials; Amino Alcohols; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digitalis Glycosides; Dogs; Heart Conduction System; In Vitro Techniques; Lidocaine; Membrane Potentials; Ouabain; Papillary Muscles; Propranolol; Sotalol; Sympatholytics | 1972 |
Functions of neurons in enteric plexuses of cat intestine.
Topics: Acetylcholine; Animals; Atropine; Cats; Electrophysiology; Epinephrine; Hexamethonium Compounds; In Vitro Techniques; Intestine, Small; Lidocaine; Muscle, Smooth; Myenteric Plexus; Neural Inhibition; Nicotine; Norepinephrine; Phenoxybenzamine; Serotonin; Sotalol; Submucous Plexus; Tetrodotoxin; Tubocurarine | 1972 |
Overdrive pacing as treatment of sotalol-induced ventricular tachyarrhythmias (torsade de pointes).
Topics: Adult; Female; Heart Rate; Humans; Lidocaine; Male; Middle Aged; Pacemaker, Artificial; Sotalol; Suicide, Attempted; Tachycardia | 1982 |
Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect.
Topics: Amiodarone; Anti-Arrhythmia Agents; Binding, Competitive; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Metoprolol; Propafenone; Receptors, Thyroid Hormone; Sotalol; Triiodothyronine; Verapamil | 1995 |
Treatment of ventricular tachycardia.
Topics: Humans; Lidocaine; Procainamide; Sotalol; Tachycardia, Ventricular | 1994 |
An in vitro method for the evaluation of antiarrhythmic and antiischemic agents by using programmed electrical stimulation of rabbit heart.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Electric Stimulation; Glycine; Heart; Heart Ventricles; In Vitro Techniques; Lidocaine; Myocardial Ischemia; Myocardial Reperfusion Injury; Rabbits; Sotalol; Ventricular Function | 1994 |
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Topics: Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Death, Sudden, Cardiac; Disease Models, Animal; Dronedarone; Female; Lidocaine; Male; Myocardial Ischemia; Sotalol; Stereoisomerism; Swine; Tachycardia, Ventricular; Ventricular Fibrillation | 1995 |
SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Chi-Square Distribution; Disease Models, Animal; Dose-Response Relationship, Drug; Dronedarone; Electrocardiography; Heart Block; Heart Rate; Injections, Intravenous; Lidocaine; Myocardial Reperfusion Injury; Random Allocation; Rats; Sotalol; Ventricular Fibrillation | 1995 |
CIBIS, MERIT-HF, and COPERNICUS trial outcomes: do they complete the chapter on beta-adrenergic blockers as antiarrhythmic and antifibrillatory drugs?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Lidocaine; Quinidine; Sotalol; Survival Rate; Treatment Outcome | 2001 |
Electrical heterogeneity and arrhythmogenesis: importance of conduction velocity dispersion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Disease Models, Animal; Electrocardiography; Electrophysiology; Heart; Heart Conduction System; Infusion Pumps; Lidocaine; Refractory Period, Electrophysiological; Sotalol; Swine; Ventricular Fibrillation | 2003 |
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes.
Topics: Animals; Cell Line; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Electrophysiology; Embryonic Stem Cells; Humans; Lidocaine; Long QT Syndrome; Mice; Myocytes, Cardiac; Patch-Clamp Techniques; Quinidine; Sotalol | 2010 |
First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model.
Topics: Acetanilides; Animals; Anti-Arrhythmia Agents; Enzyme Inhibitors; Female; Infusions, Intravenous; Injections, Intravenous; Lidocaine; Myocardial Reperfusion Injury; Piperazines; Random Allocation; Ranolazine; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Sotalol; Statistics, Nonparametric; Tachycardia, Ventricular; Ventricular Fibrillation | 2011 |
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Defibrillators, Implantable; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Hypoglycemia; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Ischemia; Piperazines; Ranolazine; Sotalol; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome | 2011 |
Episodic syncope caused by ventricular flutter in a tiger (Panthera tigris).
Topics: Animals; Anti-Arrhythmia Agents; Lidocaine; Male; Panthera; Sotalol; Syncope; Ventricular Flutter | 2013 |
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS.
Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil | 2019 |